NCT05542420View on ClinicalTrials.gov

A Research Study, Looking at the Characterization of Treatment Intensified (Add on to Metformin) Real-world Adult Population With Type 2 Diabetes Mellitus in India, Pakistan and Thailand.

CompletedOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

April 20, 2023

Study Completion Date

April 20, 2023

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

No treatment given

The study will be based on data already recorded in the medical record

Trial Locations (3)

Unknown

Novo Nordisk Investigational Site, Bengaluru

Novo Nordisk Investigational Site, Karachi

Novo Nordisk Investigational Site, Bangkok

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT05542420 - A Research Study, Looking at the Characterization of Treatment Intensified (Add on to Metformin) Real-world Adult Population With Type 2 Diabetes Mellitus in India, Pakistan and Thailand. | Biotech Hunter | Biotech Hunter